VETAŞ

ABOUT US

Vetaş was established in 1973 to manufacture and market animal health and agricultural products, and is currently an industry leader animal health products. With 43 years of experience in preventing and treating disease, Vetaş has one of the largest product ranges in the industry. 

Vetaş products are toll manufactured at DEVA Holding manufacturing plants which have GMP (Good Manufacturing Practice) certification from the Ministry of Food, Agriculture and Animal Husbandry. Vetaş relies on support from DEVA Holding Devarge division, one of the largest R&D centers in Turkey, for product research and development. 

Vetaş is successfully integrated with the SAP and SOP systems implemented within DEVA. SAP, the world’s best and most effective reporting system, makes it possible to track and trace products in every step from purchasing of raw materials to delivery to the final consumer. 

Filings are underway around the world for animal health products manufactured for Vetaş at DEVA Holding manufacturing facilities. 

Vetaş undertakes investments within Turkey and initiatives around the world to support its mission of offering modern solutions to veterinarians for protecting animal health and treating diseases

VETAŞ HISTORY

1973

Vetaş Veteriner ve Tarım İlaçları A.Ş. is established to manufacture and market veterinary and agricultural products. 

The first products placed on the market were Vetimisin Powder for Solution for Injection and Vitaform Powder for Oral Solution. Vetimisin remains the market leader since the first day it was placed on the market. 

1976

Vetaş Oksitosin , the first oxytocin for veterinary use, and Vetaş Atropin, the first anticholinergic product in the Turkish market, are launched

1981

DEVA Holding, Vetaş’s parent company, begins manufacturing Gentamycin at its active substance manufacturing facilities, becoming one of the first 5 companies in the world that can manufacture this agent. Initiated R&D for Gentamycin-containing products for veterinary use. 

1987

The first Gentamycin-containing products are launched in the market: Gentavet Solution for Injection, Gentavet-G Eye and Ear Drops, and Gentavet-D Skin ointment. 

2002

Gentavet 10% Solution for Injection is launched. 

2006

East Pharma S.A.R.L. acquires majority stake in DEVA Holding, Vetaş’s parent company. 

2009

Vetaş moves to DEVA Holding head office building in Halkalı. 

SAP (Systems, Applications and Products in Data Processing), the world’s best and most effective reporting system for manufacturing sales and supply channels, is successfully introduced. 

2010

Helminoks Oral Tablets, an antiparasitic product containing oxfendazole and oxyclozanide, is launched. 

2011

Enteroks Powder for Oral Solution, an antibacterial product containing oxytetracycline and sulphadimidine, is launched.

Levazanid Oral Tablets, an antihelmintik product containing levamisole and oxyclozanide, is launched

2013

Vetaş celebrates 40th year in the industry. 

Vetaş enhances product range with 11 products. 

2014

DEVA Holding facilities, toll manufacturing products for Vetaş, receives GMP certification by Turkish Ministry of Food, Agriculture and Animal Husbandry. 

Vetaş introduces the pre-dispensed Beta-lactam group of products.

Vetaş introduces the first BFS-packed parenteral products in the sector (Vetkalfos Solution for Injection, Fulltonic Solution for Injection, Hydrafull Solution for Injection).

18 products were introduced, adding value to the product range. 

Aquaculture products (Diaqua, Geosol fish, Seaflor) were introduced as a new product segment. 

Launched Vetakademi Kampüs, with the slogan “Led by Science,” with educational meetings to respond to scientific needs of veterinarians. 

2015

Vetamoks LA Suspension for Injection, an antibacterial containing amoxicillin, Vetkalfos Solution for Injection, a BSF product, and Setrim Powder for Oral Solution, containing erythromycin. 

2016

As of 30.12.2016, it has merged with DEVA Holding A.Ş., the main shareholder in the company. It will continue operating within DEVA Holding A.Ş. with the Vetaş brand. 

 

VETAŞ MISSION

MISSION

Our mission is to offer veterinarians and animal breeders with customer-oriented, modern, high-quality and cost-effective solutions, recognizing the importance of animal health for human health. 

VISION

Our vision is to become a dynamic, innovative, and solution-oriented pharmaceutical company that supports rational drug use, and monitors and rapidly adapts to changing conditions, while growing steadily in the animal health products market. 


OUR VALUES

• Resilience

• Ownership 

• Innovation and development

• Trustworthiness

• Human focus

• Teamwork

 

 

VETAŞ 

Vetaş products are toll manufactured at DEVA Holding manufacturing facilities. To learn more about the manufacturing facilities, visit

www.deva.com.tr 

VETAŞ OUR MANAGER

Philipp Haas

Chairman of the Board of Directors and CEO

Philipp Haas, Chairman of the Board of Directors and CEO, Vetaş Veteriner ve Tarım İlaçları A.Ş., received his MBA in banking from the University of St. Gallen. He speaks German, English, French, Spanish, Portuguese, Italian and Turkish fluently. Philipp Haas held investment consultant and executive posts since 1992, and has vast experience in East European markets, in particular Turkey. He was involved in several reorganization projects in Ukraine and Turkey, and sat on several executive boards, representing the interests of foreign corporate investors in the 90s, including Rogan Brewery of Ukraine, and Net Holding of Turkey.

Philipp Haas has broad experience in the pharmaceutical industry, and had focused investments at East Europe when working as an advisor to investment trusts for the pharmaceutical sector in the developing world. These include Slovakpharma, which was later renamed to Zentiva.

Haas held senior posts in other companies within the group, and the post of chairman of the board of directors at EastPharma Ltd., DEVA Holding A.Ş., Saba İlaç Sanayi ve Ticaret A.Ş., New Life Yaşam Sigorta A.Ş. ile Eastpharma İlaç Üretim Pazarlama San. ve Tic. A.Ş., and member of the board of directors at EastpharmaSarl, Lypanosys Pte Limited.

 

Mesut Çetin

Vice-Chairman of the Board of Directors & CFO

Mesut Çetin, Vice-Chairman of the Board of Directors and CFO, Vetaş Veteriner ve Tarım İlaçları A.Ş., received his Bachelor’s Degree in Teaching Mathematics from Boğaziçi University, and his EMBA from Koç University.

Mesut Çetin holds to post of Vice-Chairman of the Board of Directors and CFO at DEVA Holding A.Ş., representing Vetaş Veteriner ve Tarım İlaçları A.Ş.

From 1999, he worked in various roles, including analyst, trader and project manager, at GEM Global Equities Management S.A., and between years 2005 and 2007 assumed the role of executive responsible for operations within the same group.

Mesut Çetin holds the position of Vice-Chairman of the Board of Directors and CFO at Saba İlaç Sanayi ve Ticaret A.Ş., and sits on the Board of Directors at EastPharma Ltd and EastPharma Canada Ltd., as well as other companies within the group. 

 

Ayşecik Haas

Member of the Board of Directors

Ayşecik Haas, Member of the Board of Directors, Vetaş Veteriner ve Tarım İlaçları A.Ş., graduated from Ankara Özel Yükseliş Koleji in 1991, and afterward received her Bachelor’s Degree in Electric and Electronic Engineering from Eastern Mediterranean University, and her Master’s Degree in Economics from Texas Tech University.

She embarked on her professional career in Turkey working in various engineering roles at Emek Elektrik ve Beko Elektronik, and after receiving her master’s degree in economics, worked for some time in finance roles in New York, and as an investment specialist, briefly, at Hattat Holding after repatriating to Turkey. In 2008, Ayşecik Haas held the post of General Manager at NAR Group, a media organization, and currently sits on the board of directors of DEVA Holding A.Ş. and Saba İlaç San. Ve Tic. A.Ş.